You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer

 

Online download statistics by month:

Online download statistics by month: June 2022 to July 2025

AbstractFullPdf
Jun 2022501515225
Jul 2022315319108
Aug 202225225793
Sep 202221421975
Oct 202223324077
Nov 202216316330
Dec 202212512527
Jan 202311411529
Feb 202312012355
Mar 2023939352
Apr 2023757522
May 202310710961
Jun 2023737343
Jul 2023696949
Aug 2023484827
Sep 2023393920
Oct 2023383825
Nov 2023495132
Dec 2023464728
Jan 2024393920
Feb 2024424228
Mar 2024393975
Apr 2024434430
May 2024909017
Jun 2024524933
Jul 2024777845
Aug 2024403619
Sep 20243636157
Oct 2024495026
Nov 2024535434
Dec 2024838618
Jan 2025555628
Feb 2025858726
Mar 2025444412
Apr 2025717640
May 2025465023
Jun 202524259
Jul 2025110
Total364337001718